23 Recruiting Trials

Clinical Trials
for COPD in Massachusetts

23 clinical trials for COPD are currently recruiting participants at study sites in Massachusetts. Study-related care is provided at no cost.

23
Recruiting trials
19
Study sites
6
Cities
12
Industry-sponsored
5
Phase 2
7
Phase 3

COPD clinical trials in Massachusetts: what to expect

COPD trials test new inhaler combinations, biologic injections for people whose flare-ups continue despite inhalers, and treatments for the cough and mucus that come with chronic bronchitis. Others study pulmonary rehabilitation and exercise, valves and other procedures for emphysema, home oxygen and remote monitoring, and programs to stop smoking. Most enroll people with moderate to severe disease who still have symptoms on their current treatment.

In Massachusetts, recruiting copd studies are concentrated in Boston, North Dartmouth, Burlington and Fall River, with sites in 2 other cities. 12 of the 23 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who COPD trials usually look for

Trials confirm COPD with a breathing test at screening and set a range for lung function, usually between 30 and 80 percent of predicted. Most ask for a smoking history of at least ten pack-years, though current smokers are generally accepted. Biologic trials require one or two flare-ups in the past year needing steroids or antibiotics and sometimes a blood eosinophil count above a threshold. Common exclusions are asthma as the main diagnosis, another significant lung disease and a flare-up in the past four weeks. Ages are usually 40 to 80.

What taking part involves

Screening includes spirometry, blood work and a symptom questionnaire, then a short run-in while you record symptoms. Drug trials run six to twelve months with visits every four to twelve weeks, breathing tests, a six-minute walk in some, and a diary or app. Your maintenance inhalers continue, sometimes replaced by study-supplied versions, and rescue inhaler is always allowed. Rehabilitation trials involve two or three sessions a week for eight to twelve weeks. Study care is free and visits are usually paid.

Questions worth asking the study team

Whether your inhalers stay the same; how breathing tests and walking tests are scheduled; the chance of placebo; what to do during a flare-up while enrolled; and whether oxygen users are accepted.

Showing 20 of 23 recruiting COPD trials in Massachusetts

The Effect of a Technology-Mediated Integrated Walking and Tai Chi Intervention on Physical Function in Veterans With COPD and Chronic Musculoskeletal Pain
NA Boston, Massachusetts NCT05701982
This trial is looking for veterans aged 40 and older with COPD and chronic musculoskeletal pain. Participants will engage in a walking and Tai Chi program to see if it helps improve their physical function.
Recruiting
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
NA Birmingham, Alabama +4 sites NCT05204888
This trial is looking for people with moderate to very severe COPD who have had a recent severe worsening of their condition. Participants will use the myAirvo 3 device at home while receiving their usual COPD care for at least one year.
Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
PHASE3 Foley, Alabama +4 sites NCT06883305
This trial is looking for adults with moderate to very severe COPD. Participants will be required to take part in assessments and treatments involving Tezepelumab.
Recruiting
Multi-Center Clean Air Randomized Controlled Trial in COPD
PHASE3 Birmingham, Alabama +4 sites NCT06376994
This trial is looking for people with chronic obstructive pulmonary disease (COPD) to see if using an air cleaner can help them. Participants will be asked questions about their health and will have an air cleaner placed in their home to test its effectiveness.
Recruiting
A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
PHASE2 North Dartmouth, Massachusetts +4 sites NCT07646587
This trial is looking for adults with moderate to severe COPD to test a new medication called WIN378. Participants will take the medicine and have their lung function and safety monitored.
Recruiting
Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
NA Worcester, Massachusetts NCT07072039
This trial is looking for adults with moderate to severe COPD who have had recent flare-ups requiring emergency care. Participants will receive support from specially trained paramedics at home to manage their symptoms early.
Recruiting
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
NA Birmingham, Alabama +4 sites NCT06891755
This trial is looking for adults with COPD and emphysema who experience difficulty breathing. Participants will receive a device to help open their airways and will be followed for three years.
Recruiting
A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
NA Boston, Massachusetts +3 sites NCT07119229
This trial is looking for adults with severe emphysema to test a new implant. Participants will be evaluated for their suitability based on health criteria and undergo a baseline exam.
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
PHASE3 Athens, Alabama +4 sites NCT06283966
This trial is looking for adults aged 40 to 80 with Chronic Obstructive Pulmonary Disease (COPD). Participants will receive a combination inhaler treatment and attend study visits for assessments.
Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
PHASE2 Birmingham, Alabama +4 sites NCT07082738
This trial is looking for people with moderate to very severe COPD to test the effects of a new drug called AZD6793. Participants will take AZD6793 or a placebo and help researchers learn about its safety and effectiveness.
Recruiting
Inter-lobar Fissure Completion in Patients With Failed Bronchoscopic Lung Volume Reduction
NA Boston, Massachusetts NCT05257681
This trial is looking for patients with severe emphysema or COPD who did not improve after a certain lung treatment. If you join, you may undergo a surgical procedure to help improve your lung function.
Recruiting
Combined Zephyr Valve System With Inter-lobar Fissure Completion for Lung Volume Reduction in Emphysema
NA Boston, Massachusetts NCT04801108
This trial is looking for patients with severe emphysema or COPD. Participants will undergo a surgical procedure to improve lung function and then receive a specific valve treatment.
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
PHASE3 Chandler, Arizona +4 sites NCT07190209
This trial is looking for adults aged 40 to 80 with chronic obstructive pulmonary disease (COPD) that isn't well controlled. Participants will receive either lunsekimig or a placebo for approximately 48 weeks, followed by an 8-week follow-up.
Recruiting
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
PHASE3 Sheffield, Alabama +4 sites NCT06961214
This trial is looking for adults with moderate to severe COPD and type 2 inflammation. Participants will be taking depemokimab as an additional treatment along with their current medications.
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
PHASE3 Birmingham, Alabama +4 sites NCT07190222
This trial is looking for adults aged 40 to 80 with chronic obstructive pulmonary disease (COPD) that is not well controlled. Participants will receive either lunsekimig or a placebo for about 48 weeks, followed by an 8-week follow-up.
Recruiting
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
PHASE2 Birmingham, Alabama +4 sites NCT07363694
This trial is looking for adults aged 35 to 80 with moderate to severe COPD. Participants will receive either the study medicine PF-07275315 or a placebo through shots over 24 to 68 weeks and will attend multiple clinic visits during this time.
Recruiting
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
PHASE2 Birmingham, Alabama +4 sites NCT07759245
This trial is looking for adults with moderate-to-severe COPD to test a new treatment called Brenipatide. Participants will receive either the treatment or a placebo and will be monitored for about one year.
Recruiting
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
PHASE2 Boston, Massachusetts +4 sites NCT05937854
This trial is looking for veterans with Chronic Obstructive Pulmonary Disease (COPD) and high blood pressure in the lungs who experience shortness of breath. Participants will take either the drug tadalafil or a placebo and will be monitored over six months to see if their breathing improves.
Recruiting
Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
NA Boston, Massachusetts +1 sites NCT05934565
This trial is looking for patients with COPD or heart failure who want to be more active. Participants will be randomly assigned to use a program called Mindful Steps or receive usual care for 12 months to help increase their daily steps.
Recruiting
Recruiting

Where the COPD studies are in Massachusetts

  • Beth Israel Deaconess Medical Center, Boston6 trials
  • Brigham and Women's Hospital, Boston4 trials
  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston2 trials
  • BIDMC, Boston1 trial
  • Brigham & Women's Hospital- Site Number : 8400148, Boston1 trial
  • Brigham Lung Center, Boston1 trial

Counts are recruiting studies listing at least one site in Massachusetts, from ClinicalTrials.gov, refreshed every two days.

COPD clinical trials in Massachusetts: common questions

How many COPD clinical trials are recruiting in Massachusetts?
TrialFinder currently lists 23 recruiting COPD clinical trials with study sites in Massachusetts. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are COPD clinical trials located in Massachusetts?
Study sites for the COPD trials listed on this page include Boston, North Dartmouth, Worcester. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a COPD clinical trial in Massachusetts?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many COPD trials in Massachusetts also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a COPD clinical trial in Massachusetts?
Each study sets its own criteria based on age, COPD diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Do I need to quit smoking to join a COPD trial?
Most COPD trials accept current smokers; some require that you have stopped, and smoking-cessation trials are specifically for people who still smoke. The listing states the rule.
What tests confirm COPD for a trial?
Spirometry, a breathing test done at the site before and after a bronchodilator, which gives the lung function figure trials use to set their range. You do not need recent results to ask.
Will I keep using my inhalers during a trial?
Yes. Trials add the study treatment to your maintenance inhalers or supply a standardized equivalent, and a rescue inhaler is always permitted.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to COPD trials near you in Massachusetts.

Get Matched — Free
No insurance required

COPD trials investigate bronchodilators, anti-inflammatory biologics, pulmonary rehabilitation, and lung-volume reduction procedures for chronic obstructive lung disease.

All COPD trials →